My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

OraSure Technologies, Inc. - Common Stock (NQ:OSUR)

3.115 -0.085 (-2.66%)

Streaming Delayed Price Updated: 3:26 PM EDT, Mar 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about OraSure Technologies, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

50 Biggest Movers From Yesterday ↗

September 23, 2021

Gainers Marin Software Incorporated (NASDAQ: MRIN) shares jumped 61.9% to close at $9.21 on Wednesday following an announcement from management that the company entered into a...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2021 ↗

September 22, 2021

Upgrades Argus Research upgraded the previous rating for Simon Property Group Inc (NYSE:

Via Benzinga

Earnings Scheduled For May 5, 2021 ↗

May 05, 2021

Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

OraSure Secures $205M Contract For OTC COVID-19 Tests ↗

September 20, 2021

The Defense Logistics Agency has awarded OraSure Technologies Inc (NASDAQ: OSUR) a procurement contract for its InteliSwab COVID-19 Rapid Test for over-the-counter use...

Via Benzinga

48 Biggest Movers From Friday ↗

September 20, 2021

Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by...

Via Benzinga

OraSure Stock Is Trading Lower As Q2 Earnings, Outlook Trail Estimates ↗

August 04, 2021

OraSure Technologies Inc (NASDAQ: OSUR) reported second-quarter revenues almost doubled to $57.6 million, slightly ahead of the consensus of $56.69 million. Excluding...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 04, 2021

Gainers BeyondSpring (NASDAQ:BYSI) stock increased by 337.79% to $42.16 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.6...

Via Benzinga

30 Stocks Moving in Wednesday's Pre-Market Session ↗

August 04, 2021

Gainers Alterity Therapeutics Limited (NASDAQ: ATHE) shares rose 34.8% to $1.84 in pre-market trading after gaining around 3% on Tuesday. Wheeler Real Estate Investment Trust,...

Via Benzinga

Orasure Technologies Inc (OSUR) Q2 2021 Earnings Call Transcript ↗

August 03, 2021

OSUR earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 03, 2021

Gainers Cerus (NASDAQ:CERS) shares incre...

Via Benzinga

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

14 Stocks Moving In Tuesday's After-Hours Session ↗

August 03, 2021

RingCentral (NYSE: RNG) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results and issued Q3 and FY21 EPS and sales guidance above...

Via Benzinga

OraSure Technologies: Q2 Earnings Insights ↗

August 03, 2021

Shares of OraSure Technologies (NASDAQ:OSUR) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 87.50% over...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 23, 2021

Gainers NanoVibronix (NASDAQ:NAOV) share...

Via Benzinga

Cramer Weighs In On Johnson & Johnson, ViacomCBS And More ↗

June 15, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said Johnson & Johnson (NYSE: JNJ) goes up no matter what because it has a big drug pipeline. He would own the...

Via Benzinga

OraSure's COVID-19 Rapid Antigen Tests Gets FDA Emergency Approval for OTC, Professional, Prescription Use ↗

June 07, 2021

OraSure Technologies Inc (NASDAQ: OSUR) has received FDA Emergency Use Authorization (EUA) for its COVID-19 rapid antigen tests, InteliSwab. These tests detect...

Via Benzinga

Earnings Scheduled For August 3, 2021 ↗

August 03, 2021

Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to...

Via Benzinga

OraSure Resubmits EUA Applications for ELISA COVID-19 Antibody Test ↗

May 26, 2021

OraSure Technologies Inc (NASDAQ: OSUR) has resubmitted two separate Emergency Use Authorization (EUA) applications for its SARS-CoV-2 Antibody ELISA and the oral specimen...

Via Benzinga

Orasure Technologies Inc (OSUR) Q1 2021 Earnings Call Transcript ↗

May 06, 2021

OSUR earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Stocks That Hit 52-Week Lows On Friday ↗

April 30, 2021

Friday morning saw 14 companies set new 52-week lows. Points of Interest: Lufax Holding (NYSE:LU) was the largest, in terms of market cap, to set a new 52-week low...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 20, 2021

Tuesday's morning session saw 33 companies set new 52-week lows. Highlights: The largest company by market cap to set a new 52-week low was iQIYI (NASDAQ:IQ)....

Via Benzinga

The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs ↗

May 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs ↗

April 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue ↗

April 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.